This page provides educational information about current scientific and clinical research on psilocybin. It is offered for general informational purposes only and does not constitute medical or therapeutic advice.
In recent years, psilocybin has become the subject of increasing scientific investigation, including FDA-recognized research programs studying its potential use for depression and other mental health conditions.
Peer-reviewed research published in journals including JAMA Psychiatry, and The New England Journal of Medicine, have explored psilocybin in controlled clinical settings, including studies examining depression, emotional processing, cognition, well-being, and other psychological outcomes.
Research from Oregon's Regulated Psilocybin Program
In August 2026, JAMA Network Open published one of the first large prospective studies examining outcomes from Oregon's state-regulated psilocybin services.
Researchers followed 346 adults who received psilocybin services across 24 licensed Oregon service centers and assessed participants before their experience and during the months that followed.
At one month, 92.2% of participants reported benefiting from their experience, and 58.6% ranked it among the ten most meaningful experiences of their lives. Over three months, researchers observed significant reductions in symptoms of depression, anxiety, and PTSD, alongside improvements in mental well-being and life satisfaction.
Unlike traditional clinical trials of psilocybin-assisted therapy, this research examined services delivered within Oregon's existing regulated framework, providing early real-world evidence about the experiences and outcomes of people participating in the program.
Read the 2026 Oregon study in JAMA Network Open
Research into psilocybin remains ongoing, and individual experiences and outcomes vary. Ripple Journeywork does not provide medical diagnosis or treatment. This information is shared to support public understanding of current research alongside Oregon's licensed psilocybin service framework.
